Skip to content

Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function

Levels of Caffeine Lower Than Those Found in Decaffeinated Beverages Exert Effects on Cognition, Mood, and Autonomic Activity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00487227
Enrollment
20
Registered
2007-06-18
Start date
2005-06-30
Completion date
2005-11-30
Last updated
2015-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

caffeine, coffee, decaffeinated, cognition, mood, autonomic

Brief summary

It is often assumed that levels of caffeine found in 'decaffeinated' beverages are below any psychopharmacological threshold. However, recent findings indicate that caffeine doses as low as 9 mg may be psychoactive. The effects of caffeine have also been shown up to 6 hours post-administration. The study aimed to establish the lowest active dose of caffeine, and to ascertain the duration of any effects.

Detailed description

The majority of recent caffeine studies have evaluated doses in the range of 75 - 150 mg or 1 - 2 mg/kg (approximately 130 - 260 ml fresh coffee). Such doses produce well characterised effects; including increased 'alertness', and improvements to measures of reaction time and sustained attention. A previous study has demonstrated improvements to performance following 9 mg caffeine, which represents the lowest known psychoactive dose of caffeine. A number of these effects, including elevated salivary caffeine levels, were still apparent at 6 hours post-caffeine consumption (9). Findings showing effects of 12.5 and 9 mg caffeine are important as these are approaching the levels found in decaffeinated beverages, which are assumed to have no behavioural or physiological effects. However, despite extensive research in this area, the lower threshold for psychoactive effects has not been established. A randomised, placebo-controlled, double-blind, balanced crossover study was undertaken. 20 young men and women (13 female, mean age 20.7 years, standard deviation 2.4) undertook computerised assessments of memory and attention and rated subjective mood. Autonomic activity and salivary caffeine were co-monitored. Assessment took place at baseline, 1, 3, 6, and 9 hours post-administration of placebo, 2.5, 5, and 10 mg caffeine (on separate days) administered in 150 ml fruit juice.

Interventions

DRUGcaffeine
DRUGPlacebo

Sponsors

Northumbria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* native English speaker

Exclusion criteria

* pregnancy * medication * anaemia * heart disorder * diabetes * respiratory disorder * epilepsy * asthma * panic attacks * habitual smoking * food allergy

Design outcomes

Primary

MeasureTime frame
Change from baseline speed of attention1 hour

Secondary

MeasureTime frame
Change from baseline speed of memory1 hour
Change from baseline accuracy of memory6 hours
Change from baseline subjective mood1 hour
Change from baseline accuracy of attention1 hour
Change from baseline heart rate1 hour
Change from baseline salivary caffeine levels1 hour
Change from baseline blood pressure1 hour

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026